ABOUT Michael Henson
Mr. Henson has participated in the formation of more than twenty successful emerging medical technology and biotechnology firms and currently serves on the Board of Directors of four medical firms, and is Chairman of three of the companies. Mr. Henson guided six of these firms through the IPO process to become public companies as President/CEO and/or Chairman, including companies which have reached market capitalization surpassing $1 billion. Twelve of the companies founded by Mr. Henson have been acquired by large, multinational firms. Most recently, in September 2019, Rebound Therapeutics Corporation, parent company to Viseon, Inc. and a company co-founded by Mr. Henson was acquired by Integra LifeSciences Corporation for 4 times return to shareholders.